Research Center for Tissue Repair and Regeneration Affiliated to Medical Innovation Research Department and 4th Medical Center, PLA General Hospital and PLA Medical College; PLA Key Laboratory of Tissue Repair and Regenerative Medicine and Beijing Key Research Laboratory of Skin Injury, Repair and Regeneration; Research Unit of Trauma Care, Tissue Repair and Regeneration, Chinese Academy of Medical Sciences, 2019RU051, Beijing, 100048, P. R. China.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, 999078, Macau SAR, China.
Signal Transduct Target Ther. 2023 Mar 14;8(1):116. doi: 10.1038/s41392-023-01343-5.
The ageing process is a systemic decline from cellular dysfunction to organ degeneration, with more predisposition to deteriorated disorders. Rejuvenation refers to giving aged cells or organisms more youthful characteristics through various techniques, such as cellular reprogramming and epigenetic regulation. The great leaps in cellular rejuvenation prove that ageing is not a one-way street, and many rejuvenative interventions have emerged to delay and even reverse the ageing process. Defining the mechanism by which roadblocks and signaling inputs influence complex ageing programs is essential for understanding and developing rejuvenative strategies. Here, we discuss the intrinsic and extrinsic factors that counteract cell rejuvenation, and the targeted cells and core mechanisms involved in this process. Then, we critically summarize the latest advances in state-of-art strategies of cellular rejuvenation. Various rejuvenation methods also provide insights for treating specific ageing-related diseases, including cellular reprogramming, the removal of senescence cells (SCs) and suppression of senescence-associated secretory phenotype (SASP), metabolic manipulation, stem cells-associated therapy, dietary restriction, immune rejuvenation and heterochronic transplantation, etc. The potential applications of rejuvenation therapy also extend to cancer treatment. Finally, we analyze in detail the therapeutic opportunities and challenges of rejuvenation technology. Deciphering rejuvenation interventions will provide further insights into anti-ageing and ageing-related disease treatment in clinical settings.
衰老是一个从细胞功能障碍到器官退化的系统性衰退过程,更容易出现恶化的疾病。衰老指的是通过各种技术,如细胞重编程和表观遗传调控,使衰老细胞或生物体获得更年轻的特征。细胞衰老的巨大飞跃证明衰老是可以逆转的,许多抗衰老干预措施已经出现,以延缓甚至逆转衰老过程。定义阻碍因素和信号输入如何影响复杂的衰老程序,对于理解和开发抗衰老策略至关重要。在这里,我们讨论了对抗细胞再生的内在和外在因素,以及涉及这一过程的靶向细胞和核心机制。然后,我们批判性地总结了细胞衰老最新的先进策略的进展。各种抗衰老方法也为治疗特定的与衰老相关的疾病提供了思路,包括细胞重编程、衰老细胞 (SCs) 的清除和衰老相关分泌表型 (SASP) 的抑制、代谢操纵、干细胞相关治疗、饮食限制、免疫再生和异时移植等。抗衰老疗法的潜在应用也延伸到癌症治疗。最后,我们详细分析了抗衰老技术的治疗机会和挑战。解析抗衰老干预措施将为临床抗衰老和与衰老相关疾病的治疗提供进一步的思路。